30 April 2004 Active substances in PT 8 and 14 for which at least one dossier was submitted by 28 March 2004
The following tables list those existing active substances, notification of which had been accepted, within product types 8 and 14, and for which at least one dossier has been submitted to the designated Rapporteur Member State. Nota bene: The tables are made publicly available for information only. Publication does not mean that the dossiers have been accepted as complete - verification of completeness is currently ongoing. Active substances for wood preservatives Rapporteur Name (EINECS and/or others) EC Number CAS Member State
Cyclohexylhydroxydiazene 1-oxide, potassium salt
.kappa.O)diazeniumato(2-)]-copper 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-
2-nitroguanidine 3-Iodo-2-propynyl butylcarbamate
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-
ylmethyl)pentan-3-ol / Tebuconazole Thiabendazole
cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-
N-Didecyl-N-dipolyethoxyammonium borate /
Didecylpolyoxethylammonium borate Copper oxide
Copper(II) carbonate—copper(II) hydroxide (1:1)
trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea / Flufenoxuron Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-
3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-
methyl[1,1’-biphenyl]-3-ylmethyl ester, (1R,3R)-rel- / Bifenthrin / Biphenate Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-
(p-tolyl)methanesulphenamide / Tolyfluanid 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-
2-yl]methyl]-1H-1,2,4-triazole / Propiconazole
30 April 2004 Active substances for wood preservatives Rapporteur Name (EINECS and/or others) EC Number CAS Member State
Quaternary ammonium compounds, benzyl-C12-
16-alkyldimethyl, chlorides Poly(oxy-1,2-ethanediyl), .alpha.-[2-
(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt) Quaternary ammonium compounds
(benzylalkyldimethyl (alkyl from C8-C22,
saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides) / BKC Quaternary ammonium compounds
(dialkyldimethyl (alkyl from C6-C18, saturated and
unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates) / DDAC Quaternary ammonium compounds (alkyltrimethyl
(alkyl from C8-C18, saturated and unsaturated, and EINECS listed
tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates) / TMAC m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate / Permethrin 1-[2-(allyloxy)-2-(2,4-Dichlorophenyl)ethyl]-1H-
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5- Plant protection 122453-73-0
(trifluoromethyl)-1H-pyrrole-3-carbonitrile /
Active substances for rodenticides Rapporteur Name (EINECS and/or others) EC Number CAS Member State
.alpha.,.alpha.,.alpha.-trifluoro-N-methyl-4,6-
dinitro-N-(2,4,6-tribromophenyl)-o-toluidine /
30 April 2004
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-
4-hydroxycoumarin / Difenacoum 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-
tetrahydro-1-naphthyl)coumarin / Brodifacoum Warfarin
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-
(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin / Flocoumafen Chloralose
3-[3-(4'-bromo[1,1'-biphenyl]-4-yl)-3-hydroxy-1-
phenylpropyl]-4-hydroxy-2-benzopyrone / Bromadiolone 3-(3-(4’-Bromo-(1,1’-biphenyl)-4-yl)-1,2,3,4-
tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-
2-one / 3-((RS,3RS;1RS,3SR)-3-(4'-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one / Difethialone
AN ORGANISATION FOR PROMOTING UNDERSTANDING OF SOCIETY "Peru and the World at the Dawn of 2009" Report of a Listening Post held in January Encouraging The Reflective Citizen Part 1. THE SHARING OF PREOCCUPATIONS AND EXPERIENCES In this part of the Listening Post participants were invited to identify, contribute, and explore their experience in their various social roles, b
Beaumont forms hybrid research and device labBeaumont Health System plans to open one of the nation’s first hospital-based combination cardiovascular research and physician training centers at the Royal Oak campus this fall, as part of its mission as a center for medical education. The Beaumont Center for Innovation and Research in Cardiovascular Disease (CIRC) will conduct medical devic